PTPA and lung adenocarcinoma: Therefore, we compared the DAPs from the PP2A-inhibited cells with non–small-cell lung cancer patient ATAC-seq profiles, including lung adenocarcinoma and lung squamous cell carcinoma (Wang et al, 2019).